Dermatology online journal最新文献_第2页

A novel presentation of calcinosis cutis of the scalp in adult dermatomyositis. 成人皮肌炎中头皮钙质沉着的新表现。

Dermatology online journal Pub Date : 2025-02-15 DOI: 10.5070/D331164984

Charles Teames, Scott R Florell, Christopher Hansen

引用次数: 0

Squamous cell carcinoma originating in folliculitis decalvans. 鳞状细胞癌起源于脱斑状毛囊炎。

Dermatology online journal Pub Date : 2025-02-15 DOI: 10.5070/D331164986

Yen Luu, Brooks D Kimmis, Anika Pulumati, Sandra Jaroonwanichkul, Garth Fraga, Anand Rajpara

引用次数: 0

Risks of topical corticosteroid therapy and role for advanced targeted topical treatments for inflammatory skin diseases: an expert consensus panel. 局部皮质类固醇治疗的风险和炎性皮肤病的高级靶向局部治疗的作用：专家共识小组。

Dermatology online journal Pub Date : 2025-02-15 DOI: 10.5070/D331164978

Joshua Burshtein, Raj Chovatiya, Alexandra Golant, Danny Zakria, Milaan Shah, Peter Lio, Mark Lebwohl

{"title":"Risks of topical corticosteroid therapy and role for advanced targeted topical treatments for inflammatory skin diseases: an expert consensus panel.","authors":"Joshua Burshtein, Raj Chovatiya, Alexandra Golant, Danny Zakria, Milaan Shah, Peter Lio, Mark Lebwohl","doi":"10.5070/D331164978","DOIUrl":"https://doi.org/10.5070/D331164978","url":null,"abstract":"Topical corticosteroids are a first-line therapy for inflammatory skin diseases and are commonly used for chronic management. Topical corticosteroids can lead to cutaneous and systemic adverse events. The purpose of this expert consensus panel was to review published literature on the safety and efficacy of topical corticosteroids and role for advanced targeted topical therapies for inflammatory skin diseases. A comprehensive literature search was completed using a combination of keywords: \"topical,\" \"corticosteroid,\" \"non-steroid,\" \"efficacy,\" \"adverse effects,\" \"malpractice,\" and \"inflammatory skin diseases.\" Articles were screened for relevance to topic of safety and efficacy of topical corticosteroids and noncorticosteroid therapies for inflammatory skin diseases. A panel of four dermatologists with expertise treating inflammatory skin diseases reviewed the articles and created consensus statements. A modified Delphi process was used to approve each statement and a strength of recommendation was assigned. The literature search produced 350 articles. A screening of the studies resulted in 24 articles that met criteria. The panel unanimously voted to adopt 10 consensus statements and recommendations. Topical corticosteroids and systemic corticosteroids are associated with numerous adverse effects, and medical-legal risks for clinicians prescribing these medications exist. Advanced targeted topical therapies have demonstrated safety and effectiveness as an alternative to corticosteroids.","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144316149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Urgent care in dermatology: first year experience of an academic clinic. 皮肤科急诊护理：学术诊所的第一年经验。

Dermatology online journal Pub Date : 2025-02-15 DOI: 10.5070/D331164972

Tara Suresh, Bruin Pollard, Hana Hajda, Lily Chen, Ilana Rosman

引用次数: 0

A case of mixed mycosis fungoides and superficial morphea: a clinicohistopathologic challenge. 蕈样霉菌病和浅表性morphea混合病例：临床组织病理学挑战。

Dermatology online journal Pub Date : 2025-02-15 DOI: 10.5070/D331164985

Oluwaseyi O Adeuyan, Celine M Schreidah, Lauren M Fahmy, Emily R Gordon, Brigit A Lapolla, Larisa J Geskin

引用次数: 0

A unique presentation of diffuse multiple eruptive milia. 弥漫性多发发疹的独特表现。

Dermatology online journal Pub Date : 2025-02-15 DOI: 10.5070/D331164967

Mckenzie DiLeo, Reece Moore, Emelie E Nelson, Rashid M Rashid

引用次数: 0

Clinical pearls addressing hair growth and loss in transgender patients on hormone replacement therapy. 在激素替代治疗中处理变性患者头发生长和脱落的临床珍珠。

Dermatology online journal Pub Date : 2025-02-15 DOI: 10.5070/D331164961

Chinenye Onejeme, Mary Fitzgibbon, Antonio Jimenez, Lindy Ross

{"title":"Clinical pearls addressing hair growth and loss in transgender patients on hormone replacement therapy.","authors":"Chinenye Onejeme, Mary Fitzgibbon, Antonio Jimenez, Lindy Ross","doi":"10.5070/D331164961","DOIUrl":"https://doi.org/10.5070/D331164961","url":null,"abstract":"Hair is a defining feature of human appearance and plays an essential role in personality and identity development. Currently, about 1.6% of US adults identify as transgender. Within the transgender community, hair serves not only as a means of self-expression but also as a crucial element in affirming gender identity, helping individuals to align their outward appearance with their inner sense of self. However, there are significant disparities in the care provided to transgender patients, particularly those seeking a more masculine or feminine appearance through hormone replacement therapy. Studies on transgender patient satisfaction with current therapies are limited but indicate overall dissatisfaction with the standard of care. Dermatologists play a pivotal role in advocating and caring for transgender patients regarding their hair and skin needs. A deeper understanding of hormone replacement therapy and hair growth/loss therapy is crucial to prescribing medications aligned with patients' treatment goals. This commentary aims to provide clinical guidance to dermatologists, aiding them in educating transgender patients undergoing hormone replacement therapy about accessible options for hair growth and loss. Treatment algorithms have been proposed based on efficacy, pharmacodynamic interactions with hormone replacement therapy, cost-effectiveness, adverse reactions, and care accessibility tailored specifically for transfeminine and transmasculine patients.","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144316139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Rituximab treatment of refractory skin involvement in anti-TIF1 gamma dermatomyositis. 利妥昔单抗治疗难治性皮肤受累的抗tif1 γ皮肌炎。

Dermatology online journal Pub Date : 2025-02-15 DOI: 10.5070/D331164969

Fatma Said, Maysam Jridi, Ines Naceur, Tayssir Ben Achour, Monia Smiti

{"title":"Rituximab treatment of refractory skin involvement in anti-TIF1 gamma dermatomyositis.","authors":"Fatma Said, Maysam Jridi, Ines Naceur, Tayssir Ben Achour, Monia Smiti","doi":"10.5070/D331164969","DOIUrl":"https://doi.org/10.5070/D331164969","url":null,"abstract":"Dermatomyositis is one type among a heterogeneous group of idiopathic inflammatory myopathies. Among these anti-TIF1 gamma dermatomyositis is characterized by specific skin lesions, often severe and refractory to conventional treatments. We report a 58-year-old woman who had fatigue associated with myalgia with proximal and bilateral muscle weakness along with a generalized lilac erythematous rash on the face with Gottron papules on the metacarpophalangeal joints and periungual erythema on both hands. She also exhibited a widespread dark-violaceous-red skin eruption on the whole trunk. She was diagnosed with anti-TIF1 gamma dermatomyositis and received a treatment regimen of topical corticosteroids, hydroxychloroquine, oral corticosteroids, and conventional immunosuppressive drugs (methotrexate, azathioprine, mycophenolate mofetil, cyclophosphamide, and immunoglobulins) with no improvement of the skin rash. Therefore, she received rituximab, and three months later, the skin lesions improved magnificently. Rituximab is an efficient and safe option for patients with dermatomyositis-related skin disease refractory to conventional treatments.","PeriodicalId":11040,"journal":{"name":"Dermatology online journal","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144316150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Recalcitrant Nicolau syndrome following repeated intramuscular diclofenac injections. 反复肌注双氯芬酸后的顽固性尼可劳综合征。

Dermatology online journal Pub Date : 2025-02-15 DOI: 10.5070/D331164973

Ismail H Unal, Gulsen Akoglu, Gulcin Simsek

引用次数: 0

Early malignant syphilis in an immunocompetent young man. 免疫能力强的青年早期恶性梅毒。

Dermatology online journal Pub Date : 2025-02-15 DOI: 10.5070/D331164981

Jesus Enrique Duenaz-Diaz, Dinorah Elizabeth Paz-Luna, Isaias Giovanni Duenaz-Diaz, Astrid Salcedo-Gomez, Gema Yasmin Aguilar-Roman, Vanesa Paredes-Solis, Sara Elena Chavez-Guzman, Elsa Daniela Zavala-Alvarez

引用次数: 0